FDA Investigator Hyung Yul Lee
Hyung Yul Lee has conducted inspections on 4 sites in 3 countries as of 03 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
03 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Korea (Republic of),
United States of America,
India
FDA Investigators that have inspected at least one site in common with Hyung Yul Lee:
Aditi S Thakur,
Alan L Truong,
Alicia M Mozzachio,
Andrew J Barrowcliff,
Arsen Karapetyan,
Ashar P Parikh,
Bijoy Panicker,
Bo Chi, PhD,
Charles Yuanchia Kuo, PhD,
Chiang Syin, PhD,
Concepcion Cruz, Jr,
Cristina Ausin Moreno, PhD,
Daniel J Roberts,
Deborah Schmiel, PhD,
Diane L Raccasi,
Dogbeda F Mackenzie,
Dr. Ralph M Bernstein, PhD,
Eboni S Funderburk,
Edwin Jao,
Emilie E Kahn,
Esther C Broner, PhD,
Hao Kiet D Phan,
Haoheng Yan, PhD,
Jacek Cieslak, PhD,
Jacob G Lutz,
James A Lane,
Jeanne Fringer, PhD,
Jeffrey D Meng,
Jeffrey P Raimondi,
Jon P Antoniou,
Joslyn K Brunelle, PhD,
Junho Pak,
Justin A Boyd,
Kristin M Abaonza,
Kurt A Brorson, PhD,
Lakshmi Narasimhan, PhD,
Laurel A Beer,
LCDR Sean Byrd,
Leslie Arivera Rosado, PhD,
Logan T Williams,
Lucila B Nwatu,
Madushini Dharmasena, PhD,
Maria Cruz Fisher,
Maria Gutierrez Lugo, PhD,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Massod Rahimi, PhD,
Matthew B Casale,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Monica Markovski, PhD,
Muna Algharibeh,
Nicholas L Paulin,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Patrick J Lynch,
Peter Adams, PhD,
Phillip Angart, PhD,
Prabhu P Raju,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Robert Barbosa,
Robert M Barbosa,
Saleem A Akhtar,
Sandra A Boyd,
Sarah Arden,
Sarah Kennett, PhD,
Sargum C Sood,
Scott N Lim,
Scott R Nichols, PhD,
Sneha S Patel,
Steven Fong, MS, PhD,
Stuart W Russell,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
Vaishali J Patel,
Virginia Carroll, PhD,
Viviana Matta,
Wayne E Seifert,
Wendy G Tan, PhD,
Yanming An, PhD,
Yuan Chia Kuo,
Yun Wu, PhD,
Zhong Li, PhD
Hyung Yul Lee's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2023 | FDA 483 | Samsung Biologics Co., Ltd. - Form 483, 2023-09-01 |
May, 2023 | FDA 483 | Catalent Indiana, LLC - Form 483, 2023-05-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more